Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
— Study will enrol up to 110 patients in immunotherapy relapsed/refractory RCC and NSCLC —…
— Study will enrol up to 110 patients in immunotherapy relapsed/refractory RCC and NSCLC —…
SAN JOSE, Calif.--(BUSINESS WIRE)--Momentus Inc. (NASDAQ: MNTS) ("Momentus" or the "Company"), a U.S. commercial space…
— Study will enrol up to 110 patients in immunotherapy relapsed/refractory RCC and NSCLC —…
DUBLIN--(BUSINESS WIRE)--The "India Automotive Cybersecurity Market: Prospects, Trends Analysis, Market Size and Forecasts up to…
NOIDA, India & NEW YORK--(BUSINESS WIRE)--#AI--HCLSoftware, a division of HCL Technologies (HCLTech), launched its new…
NOIDA, India & NEW YORK--(BUSINESS WIRE)--#AI--HCLSoftware, a division of HCL Technologies (HCLTech), launched its new…
Outlook promising as Hong Kong withdraws hotel quarantine HONG KONG--(BUSINESS WIRE)--The Eco Expo Asia 2022,…
Outlook promising as Hong Kong withdraws hotel quarantine HONG KONG--(BUSINESS WIRE)--The Eco Expo Asia 2022,…
TRT World held its annual World Citizen Awards ceremony in Istanbul on November 25 to…
TRT World held its annual World Citizen Awards ceremony in Istanbul on November 25 to…